|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities available-for-sale, at fair value (amortized cost: $1,438,702 and $1,432,454 in 2026 and 2025, respectively) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Other long-term investments (portion measured at fair value $82,979 and $85,157 in 2026 and 2025, respectively) | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents (restricted portion: $1,554 in both 2026 and 2025) | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Receivable for securities | ||||||||||||||||||||
| Reinsurance recoverable | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Cost of insurance acquired | ||||||||||||||||||||
| Current federal income tax receivable | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Due premiums | ||||||||||||||||||||
| Other assets (less allowance for losses of $732 and $740 in 2026 and 2025, respectively) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Policy liabilities: | ||||||||||||||||||||
| Life insurance | ||||||||||||||||||||
| Accident & health insurance | ||||||||||||||||||||
| Total future policy benefit reserves | ||||||||||||||||||||
| Future policy benefit reserve | ||||||||||||||||||||
| Life Insurance Product Line | ||||||||||||||||||||
| Accident and Health Insurance Product Line | ||||||||||||||||||||
| Total future policy benefit reserve | ||||||||||||||||||||
| Annuities | ||||||||||||||||||||
| Dividend accumulations | ||||||||||||||||||||
| Premiums paid in advance | ||||||||||||||||||||
| Policy claims payable | ||||||||||||||||||||
| Other policyholders' funds | ||||||||||||||||||||
| Total policyholder funds | ||||||||||||||||||||
| Total policy liabilities | ||||||||||||||||||||
| Commissions payable | ||||||||||||||||||||
| Current federal income tax payable | ||||||||||||||||||||
| Deferred federal income tax liability | ||||||||||||||||||||
| Payable for securities in process of settlement | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Common Stock Class A | ||||||||||||||||||||
| Common Stock Class B | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
| Common Stock Class A | ||||||||||||||||||||
| Common Stock Class B | ||||||||||||||||||||
| Total common stock, shares issued (in shares) | ||||||||||||||||||||
Loading...
